FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1127360684> ?p ?o ?g. }

• W1127360684 endingPage "8920" @default.
• W1127360684 startingPage "8920" @default.
• W1127360684 abstract "To assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and association with drug induced liver injury (DILI) in patients undergoing anti-tuberculosis (TB) therapy.Four hundred and twenty nine patients with newly diagnosed TB - either active disease or latent infection - who were due to commence anti-TB therapy between September 2008 and May 2011 were included. These patients were prospectively tested for serological markers of HBV, HCV and human immunodeficiency virus (HIV) infections - hepatitis B core antigen (HBcAg), hepatitis B surface antigen (HBsAg), hepatitis B e antigen, IgG and IgM antibody to HBcAg (anti-HBc), HCV IgG antibody and HIV antibody using a combination of enzyme-linked immunosorbent assay, Western blot assay and polymerase chain reaction techniques. Patients were reviewed at least monthly during the TB treatment initiation phase. Liver function tests were measured prior to commencement of anti-TB therapy and 2-4 wk later. Liver function tests were also performed at any time the patient had significant nausea, vomiting, rash, or felt non-specifically unwell. Fisher's exact test was used to measure significance in comparisons of proportions between groups. A P value of less than 0.05 was considered statistically significant.Of the 429 patients, 270 (62.9%) had active TB disease and 159 (37.1%) had latent TB infection. 61 (14.2%) patients had isolated anti-HBc positivity, 11 (2.6%) were also HBsAg positive and 7 (1.6%) were HCV-antibody positive. 16/270 patients with active TB disease compared to 2/159 patients with latent TB infection had markers of chronic viral hepatitis (HBsAg or HCV antibody positive; P = 0.023). Similarly the proportion of HBsAg positive patients were significantly greater in the active vs latent TB infection group (10/43 vs 1/29, P = 0.04). The prevalence of chronic HBV or HCV was significantly higher than the estimated United Kingdom prevalence of 0.3% for each. We found no association between DILI and presence of serological markers of HBV or HCV. Three (5.3%) patients with serological markers of HBV or HCV infection had DILI compared to 25 (9.5%) patients without; P = 0.04.Viral hepatitis screening should be considered in TB patients. DILI risk was not increased in patients with HBV/HCV." @default.
• W1127360684 created "2016-06-24" @default.
• W1127360684 creator A5003397190 @default.
• W1127360684 creator A5005117084 @default.
• W1127360684 creator A5027623234 @default.
• W1127360684 creator A5038231150 @default.
• W1127360684 creator A5054519729 @default.
• W1127360684 creator A5064420382 @default.
• W1127360684 creator A5068084199 @default.
• W1127360684 creator A5083477161 @default.
• W1127360684 creator A5085092701 @default.
• W1127360684 creator A5088660672 @default.
• W1127360684 date "2015-01-01" @default.
• W1127360684 modified "2023-09-23" @default.
• W1127360684 title "Viral hepatitis prevalence in patients with active and latent tuberculosis" @default.
• W1127360684 cites W104367154 @default.
• W1127360684 cites W143612168 @default.
• W1127360684 cites W1966268750 @default.
• W1127360684 cites W1971565905 @default.
• W1127360684 cites W1978505198 @default.
• W1127360684 cites W1984974276 @default.
• W1127360684 cites W2008209529 @default.
• W1127360684 cites W2020976497 @default.
• W1127360684 cites W2030711125 @default.
• W1127360684 cites W2042307442 @default.
• W1127360684 cites W2054190445 @default.
• W1127360684 cites W2060192843 @default.
• W1127360684 cites W2071385801 @default.
• W1127360684 cites W2108801026 @default.
• W1127360684 cites W2109028417 @default.
• W1127360684 cites W2113864802 @default.
• W1127360684 cites W2118510540 @default.
• W1127360684 cites W2157712198 @default.
• W1127360684 cites W2163334757 @default.
• W1127360684 cites W2166822423 @default.
• W1127360684 cites W2334541882 @default.
• W1127360684 cites W3030265267 @default.
• W1127360684 cites W4240051718 @default.
• W1127360684 doi "https://doi.org/10.3748/wjg.v21.i29.8920" @default.
• W1127360684 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4528035" @default.
• W1127360684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26269682" @default.
• W1127360684 hasPublicationYear "2015" @default.
• W1127360684 type Work @default.
• W1127360684 sameAs 1127360684 @default.
• W1127360684 citedByCount "18" @default.
• W1127360684 countsByYear W11273606842015 @default.
• W1127360684 countsByYear W11273606842016 @default.
• W1127360684 countsByYear W11273606842017 @default.
• W1127360684 countsByYear W11273606842019 @default.
• W1127360684 countsByYear W11273606842020 @default.
• W1127360684 countsByYear W11273606842021 @default.
• W1127360684 countsByYear W11273606842022 @default.
• W1127360684 countsByYear W11273606842023 @default.
• W1127360684 crossrefType "journal-article" @default.
• W1127360684 hasAuthorship W1127360684A5003397190 @default.
• W1127360684 hasAuthorship W1127360684A5005117084 @default.
• W1127360684 hasAuthorship W1127360684A5027623234 @default.
• W1127360684 hasAuthorship W1127360684A5038231150 @default.
• W1127360684 hasAuthorship W1127360684A5054519729 @default.
• W1127360684 hasAuthorship W1127360684A5064420382 @default.
• W1127360684 hasAuthorship W1127360684A5068084199 @default.
• W1127360684 hasAuthorship W1127360684A5083477161 @default.
• W1127360684 hasAuthorship W1127360684A5085092701 @default.
• W1127360684 hasAuthorship W1127360684A5088660672 @default.
• W1127360684 hasBestOaLocation W11273606841 @default.
• W1127360684 hasConcept C126322002 @default.
• W1127360684 hasConcept C142724271 @default.
• W1127360684 hasConcept C159047783 @default.
• W1127360684 hasConcept C159654299 @default.
• W1127360684 hasConcept C203014093 @default.
• W1127360684 hasConcept C2522874641 @default.
• W1127360684 hasConcept C2777075537 @default.
• W1127360684 hasConcept C2777382497 @default.
• W1127360684 hasConcept C2777410769 @default.
• W1127360684 hasConcept C2777975735 @default.
• W1127360684 hasConcept C2779729466 @default.
• W1127360684 hasConcept C2779806340 @default.
• W1127360684 hasConcept C2780593183 @default.
• W1127360684 hasConcept C2781069245 @default.
• W1127360684 hasConcept C2992208098 @default.
• W1127360684 hasConcept C45189115 @default.
• W1127360684 hasConcept C71924100 @default.
• W1127360684 hasConcept C90924648 @default.
• W1127360684 hasConceptScore W1127360684C126322002 @default.
• W1127360684 hasConceptScore W1127360684C142724271 @default.
• W1127360684 hasConceptScore W1127360684C159047783 @default.
• W1127360684 hasConceptScore W1127360684C159654299 @default.
• W1127360684 hasConceptScore W1127360684C203014093 @default.
• W1127360684 hasConceptScore W1127360684C2522874641 @default.
• W1127360684 hasConceptScore W1127360684C2777075537 @default.
• W1127360684 hasConceptScore W1127360684C2777382497 @default.
• W1127360684 hasConceptScore W1127360684C2777410769 @default.
• W1127360684 hasConceptScore W1127360684C2777975735 @default.
• W1127360684 hasConceptScore W1127360684C2779729466 @default.
• W1127360684 hasConceptScore W1127360684C2779806340 @default.
• W1127360684 hasConceptScore W1127360684C2780593183 @default.
• W1127360684 hasConceptScore W1127360684C2781069245 @default.
• W1127360684 hasConceptScore W1127360684C2992208098 @default.

• next